A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

351

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Asthma
Interventions
DRUG

fluticasone propionate

fluticasone propionate 100mcg HFA

DRUG

fluticasone propionate/salmeterol

fluticasone propionate/salmeterol 100/50mcg HFA

Trial Locations (55)

3052

GSK Investigational Site, Parkville

3168

GSK Investigational Site, Clayton

6001

GSK Investigational Site, Subiaco

6720

GSK Investigational Site, México

14850

GSK Investigational Site, Cortland

15241

GSK Investigational Site, Pittsburgh

21502

GSK Investigational Site, Geesthacht

27607

GSK Investigational Site, Raleigh

29407

GSK Investigational Site, Charleston

30120

GSK Investigational Site, Murcia

30501

GSK Investigational Site, Gainesville

30720

GSK Investigational Site, San Javier (Murcia)

31020

GSK Investigational Site, Chihuahua City

32207

GSK Investigational Site, Jacksonville

33332

GSK Investigational Site, Gütersloh

38138

GSK Investigational Site, Germantown

44718

GSK Investigational Site, Canton

44791

GSK Investigational Site, Bochum

46483

GSK Investigational Site, Wesel

47533

GSK Investigational Site, Kleve-Materborn

48197

GSK Investigational Site, Ypsilanti

55131

GSK Investigational Site, Mainz

64988

GSK Investigational Site, Monterrey N.L

73120

GSK Investigational Site, Oklahoma City

80206

GSK Investigational Site, Denver

80401

GSK Investigational Site, Lakewood

90806

GSK Investigational Site, Long Beach

90808

GSK Investigational Site, Long Beach

92506

GSK Investigational Site, Riverside

92647

GSK Investigational Site, Huntington Beach

97035

GSK Investigational Site, Lake Oswego

97213

GSK Investigational Site, Portland

97504

GSK Investigational Site, Medford

119435

GSK Investigational Site, Moscow

191144

GSK Investigational Site, St'Petersburg

630099

GSK Investigational Site, Novosibirsk

8360156

GSK Investigational Site, Santiago

05403

GSK Investigational Site, South Burlington

A1E 2C2

GSK Investigational Site, St. John's

L6T 3T1

GSK Investigational Site, Brampton

L5A 3V4

GSK Investigational Site, Mississauga

N7T 4X3

GSK Investigational Site, Sarnia

Unknown

GSK Investigational Site, Viña del Mar

GSK Investigational Site, Santiago

GSK Investigational Site, San José

LV5001

GSK Investigational Site, Ogre

LV1050

GSK Investigational Site, Riga

LT-50009

GSK Investigational Site, Kaunas

LT-28151

GSK Investigational Site, Utena

LT-01117

GSK Investigational Site, Vilnius

04530

GSK Investigational Site, Mexico City

Lima 27

GSK Investigational Site, Lima

90-329

GSK Investigational Site, Lodz

34-700

GSK Investigational Site, Rabka-Zdrój

634 050

GSK Investigational Site, Tomsk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY